ClinicalTrials.Veeva

Menu

MR-Guided Laser Ablation of Prostate Bed Recurrences

Mayo Clinic logo

Mayo Clinic

Status

Withdrawn

Conditions

Prostate Tumors

Treatments

Procedure: MR-Guided Laser Ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT01743638
09-001584

Details and patient eligibility

About

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Sex

Male

Ages

50 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment.
  • Surgery is not a desirable alternative therapy at the time of enrollment
  • Radiation therapy has failed or not indicated or can be safely postponed
  • Tumor size ≤ 5 cm at its largest diameter
  • Tumor does not encompass the rectal wall or external urethral sphincter
  • Performance status is ECOG 2 or better in adults
  • Patient is able to undergo MRI

Exclusion criteria

  • Patients with pacemaker or defibrillator

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

MR-Guided Laser Ablation
Experimental group
Treatment:
Procedure: MR-Guided Laser Ablation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems